早泄的分类治疗

目的 :选择不同药物交叉治疗原发性和继发性两类早泄 ,并观察早泄分类疗法的效果。　方法 :将原发性早泄 4 8例随机分成A组 2 3例和B组 2 5例两组 ,将继发性早泄 5 2例随机分成C组 2 4例和D组 2 8例两组。给予A组和C组病人中药制剂回春如意胶囊 3粒 ,3次 /d ,口服 ;给予B组和D组病人帕罗西汀片 (Paroxetine) 2 0mg ,1次 /d ,口服 ,以上各组治疗 2 0d。以问卷方式了解治疗效果。　结果 :问卷结果表明 ,治疗后A组 5例 ( 2 2 % )有效 ,C组17例 ( 71% )有效 ,提示回春如意胶囊治疗继发性早泄的疗效显著优于原发性早泄 (P <0 .0 0 5 )。B组 17例 ( 68% )有效 ,D组 11例 ( 3 9% )有效 ,提示帕罗西汀片治疗原发性早泄的疗效显著优于继发性早泄 (P <0 .0 5 )。　结论 :有必要对早泄进行分类 ,根据早泄的类型选择药物治疗能够提高疗效。

Selective Medication for Types of Premature Ejaculation

Objectives: To treat both primary and secondary premature ejaculation with crossover medication and to observe the curative effect of classified treatment for premature ejaculation. Methods: 48 cases of primary premature ejaculation were randomly divided into Group A (23 cases) and Group B (25 cases) and 52 cases of secondary premature ejaculation were randomly divided into Group C (24 cases) and Group D (28 cases). Every case of Group A and Group C was administered oral traditional Chinese medicine Huichunruyi for twenty days and every case of Group B and Group D was administered oral drug Paroxetine for twenty days. Results: Therapeutic efficacies were shown from the questionnaire. Among the potent patients who had improved in ejaculation latency, Group A (5,22%) was significantly less than Group C (17,71%) in number and percentage and Group B (17,68%) was significantly more than Group D (11,39%), i.e.for Huichunruyi the improvement rate in secondary premature ejaculation was significantly higher than that in primary premature ejaculation (P<0.005). But for Paroxetine the rate in primary premature ejaculation was significantly higher than that in secondary premature ejaculation (P<0.005). Conclusions: It is necessary to classify premature ejaculation, to improve the curative effect using classified treatment for premature ejaculation.